COVID-19 & Diabetes Treatment: Can We Reduce the Risk of Poorer Outcomes in Our Patients with T2D? Is There a Difference Among Anti-Hyperglycemic Agents?
By
Stanford Medicine
FEATURING
Anne Peters
By
Stanford Medicine
FEATURING
Anne Peters
A Continuing Medical Education activity presented by the Project ECHO Diabetes in the Time of ...
read more ↘
read more ↘
Login to view comments.
Click here to Login
